Event Date/Time: Jul 14, 2011 End Date/Time: Jul 15, 2011
Registration Date: Jul 15, 2011
Early Registration Date: May 20, 2011
Report as Spam


With the Indian biosimilar market expected to grow to US$ 580 million by 2012, and new uses for biosimilars in new therapeutic areas being developed daily, now is the time to take action and strategically position your company to capitalise on the host of opportunities available within the biosimilar industry.

Attend CPhI’s 2nd Annual Biosimilars India 2011 taking place 14-15 July in Mumbai, specifically designed to provide you with implementable solutions and strategic guidance to overcome the most current and critical regulatory, R&D and business challenges surrounding the Indian biosimilar market.

Biosimilars India 2011 will bring together over 100 of the most senior and influential players from the biopharmaceutical industry and regulatory bodies, and will provide two intensive days of practical and in-depth analyses, benchmarking and insights into:

• Regulatory Developments – hear the very latest thinking on biosimilar regulation and understand the implications
of local and international guidelines for your biosimilars strategy
• R&D and Process Development – benefit from in-depth guidance on how to tackle the complex R&D challenges
to ensure the quality and safety of your biosimilars
• Commercialisation – learn how to maximise the potential of partnerships and outsourcing strategies to drive the
early profitability of your biosimilars business
• Innovations – benefit from a showcase of the latest emerging technologies to reduce the timeframe and cost of
your biosimilar product development

Just some of the speakers already confirmed at this early stage to share their expertise at this event:

• KK Tripathi, Adviser, Scientist ‘G’ and Member Secretary RCGM, Department of Biotechnology
• Brij Patel, Deputy Manager, Biologicals and Biotechnology Unit, Medicines and Healthcare products Regulatory Agency (MHRA)
• Roger L Williams, Chief Executive Officer, US Pharmacopoeia
• KV Subramaniam, President and Chief Executive Officer, Reliance Life Sciences
• Ganesh Kumraj, President Operations, Bharat Serums and Vaccines
• Cyrus Karkaria, President Biotech Division, Lupin Pharmaceuticals
Plus many more …

With facilitated networking built into the programme, take advantage of the frequent networking breaks, lunches,
roundtable debates, and our 1:1 meeting facility.

Register your place now by calling +91 (022) 4046 1466, emailing conferences-india@ubm.com or visiting www.biosimilars-india.com
We look forward to seeing you at the event in July.